Yongxia Yang

Yongxia Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2022 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
WCWanting Chen
Wanting Chen
QLQian Li
Qian Li
RHRanran Hou
Ranran Hou
HLHuaguo Liang
Huaguo Liang
YZYongli Zhang
Yongli Zhang
YYYongxia Yang
Yongxia Yang

3 December 2021 in Molecular Omics
Verified
Journal Article
Closed access
PDF file
YLYing Liu
Ying Liu
CQCuiling Qi
Cuiling Qi
LZLingyun Zheng
Lingyun Zheng
JLJiangchao Li
Jiangchao Li
LWLijing Wang
Lijing Wang
YYYongxia Yang
Yongxia Yang
A 1H NMR-based metabonomic approach was applied to monitor the alterations of serum metabolic profiles in MMTV-PyMT transgenic mice to detect the dynamic changes associated with the pathological process and explore the early-stage biomarkers. The 1H NMR spectra of sera samples from four different stages in MMTV-PyMT mice including hyperplasia, adenoma, early carcinoma and late carcinoma stages were recorded and analyzed using multivariate statistical techniques. The results showed that the increased levels of lipid and lactate, and decreased leucine/isoleucine, valine, methionine, glutamine, creatine, PC/GPC, taurine and glucose were of significance for the early carcinoma stage. As the disease progressed (late carcinoma stage), the metabolic profiles changed significantly; some were negatively regulated compared with those at the early carcinoma stage, such as lipid, leucine/isoleucine, methionine and creatine, accompanied by other new metabolite changes of alanine, pyruvate, glutamate, citrate, aspartate, myo-inositol, 3-methylhistidine and formate. It is important to note that breast cancer patients and the early carcinoma stage of MMTV-PyMT mice had some similar metabolite changes, including lipid, lactate, glutamine, creatine, taurine and glucose, which were determined to be of great value for the early clinical diagnosis of breast cancer. The findings from this study provided valuable biomarkers for the early clinical diagnosis of breast cancer, and showed the potential power of integrating NMR techniques and pattern recognition methods for the analysis of the biochemical changes under certain pathophysiological conditions.